Remove keyword financials
article thumbnail

Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Fleurence, PhD, MSc; Joshua M. Sharfstein, MD)

Rethinking Clinical Trials

The economic benefits of a Hepatitis C elimination program would save lives and have enormous financial benefits to Medicare and Medicaid, paying for the program within 10 years. with the rate of reported acute Hepatitis C cases increasing 400% during 2010-2020.

article thumbnail

Grand Rounds September 15, 2023: Effect of Financial Incentives and Default Options on Food Choices of Adults With Low Income in Online Retail Settings (Pasquale Rummo, PhD, MPH)

Rethinking Clinical Trials

I would love for the financial incentive for fruits and vegetables for participants to remain a permanent strategy. I want to acknowledge that there’s definitely questions about the sustainability of types of behavior changes like the default options or even the economic incentives. My thoughts differ for each strategy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Life Science Marketers: How to Connect Content to B2B Revenue Growth

XTalks

By strategically leveraging content, businesses can drive revenue growth and achieve their financial objectives. Content marketing not only builds trust and credibility but also helps in driving brand awareness which attracts potential customers.

article thumbnail

Prominent Reasons Behind The Failure Of NAMPT inhibitors And Key Strategies Adopted By Developers To Overcome Such Challenges

Roots Analysis

As a starting point, the information on terminated, suspended and withdrawn trials was collated from clinicaltrials.gov and PubMed using relevant search keywords. Financial Constraints: Financial constraints have also played a role in the failure of NAMPT inhibitors.